The APHRS's 2013 statement on antithrombotic therapy of patients with nonvalvular atrial fibrillation

• Satoshi Ogawa, MD,
• Kazutaka Aonuma, MD,
• Hung-Fat Tse, MD,
• Dejia Huang, MD,
• Jin-Long Huang, MD,
• Jonathan Kalman, MD,
• Shiro Kamakura, MD,
• Mohan Nair, MD,
• Dong-Gu Shin, MD,
• Martin Stiles, MD,
• Wee Siong Teo, MD,
• Teiichi Yamane, MD

Affiliations

Satoshi Ogawa, MD

International University of Health and Welfare, Mita Hospital, Tokyo, Japan

Kazutaka Aonuma, MD

Institute of Clinical Medicine, Doctoral Program in Clinical Sciences, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Japan

Hung-Fat Tse, MD

Department of Medicine, University of Hong Kong, Hong Kong, China

Dejia Huang, MD

Cardiology Department, West China Second University Hospital, Sichuan University, Sichuan, China

Jin-Long Huang, MD

Taichung Veterans General Hospital/National Yang-Ming University, Taipei, Taiwan

Jonathan Kalman, MD

Department of Cardiology, Royal Melbourne Hospital, Melbourne, Australia

Shiro Kamakura, MD

National Cerebral and Cardiovascular Center, Osaka, Japan

Mohan Nair, MD

Cardiology, Max Heart and Vascular Institute, Delhi, India

Dong-Gu Shin, MD

Internal Medicine/Cardiovascular Division, Yeungnam University Hospital, Daegu, Republic of Korea

Martin Stiles, MD

Department of Cardiology, Waikato Hospital, Hamilton, New Zealand

Wee Siong Teo, MD

Department of Cardiology, National Heart Centre, Singapore, Singapore

Teiichi Yamane, MD

Jikei University School of Medicine, Tokyo, Japan